Interactions between 8-L-arginine vasopressin and prostaglandin E2 in human mononuclear phagocytes.
Open Access
- 1 April 1983
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 71 (4) , 884-891
- https://doi.org/10.1172/jci110842
Abstract
The effect of 8-L-arginine vasopressin (AVP) on biosynthesis of prostaglandins in human mononuclear phagocytes was examined. AVP, oxytocin, and deamino-(8-D-arginine) vasopressin (dDAVP) affected prostaglandin biosynthesis in a rank order that parallels their pressor but not antidiuretic activity (AVP greater than oxytocin greater than dDAVP). Radioimmunoassay, incorporation studies using [14C]arachidonic acid and radiometric thin-layer chromatography, revealed prostaglandin E2 (PGE2) to be the only prostaglandin synthesized by the mononuclear phagocytes. While high concentrations of PGE2 elevated cytoplasmic levels of cyclic AMP by five- to sevenfold above basal values, low concentrations of PGE2 that are released by the cells in the presence of AVP failed to increase cyclic AMP content in the cells. However, PGE2 at concentrations that do not alter cyclic AMP levels markedly interferes with the activity of AVP. This effect is, however, very time dependent. Addition of PGE2 to the cells 30 min before AVP, was followed by a period of unresponsiveness to the hormone that lasts at least 30 min. Pretreatment of the cells with indomethacin enhanced the AVP-mediated accumulation of intracellular cyclic AMP level. PGE2 did not modify [3H]AVP binding, indicating that its inhibitory effect on the activity of the peptide is not due to downregulation of vasopressin receptors.This publication has 21 references indexed in Scilit:
- 125I-8-L-arginine vasopressin binding to human mononuclear phagocytes.Journal of Clinical Investigation, 1981
- Vasopressin-prostaglandin interactions in the regulation of epithelial cell permeability to waterKidney International, 1981
- Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.The Journal of Experimental Medicine, 1978
- [1-(.beta.-Mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),4-valine, 8-D-arginine]vasopressin, a potent and selective inhibitor of the vasopressor response to arginine-vasopressinJournal of Medicinal Chemistry, 1978
- Vasopressin-stimulated prostaglandin E biosynthesis in the toad urinary bladder. Effect of water flow.Journal of Clinical Investigation, 1977
- In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to vasopressin.Journal of Clinical Investigation, 1977
- In vitro release of prostaglandins from the renal medullaEuropean Journal of Pharmacology, 1972
- Effects of vasopressin and prostaglandin E1 on the adenyl cyclase—cyclic 3′,5′-adenosine monophosphate system of the renal medulla of the ratJournal of Clinical Investigation, 1971
- The Glomerular Permeability Determined by Dextran Clearance Using Sephadex Gel FiltrationScandinavian Journal of Clinical and Laboratory Investigation, 1968
- Effect of Prostaglandin (PGEI) on the Permeability Response of Toad Bladder to Vasopressin, Theophylline and Adenosine 3′,5′-monophosphateNature, 1965